Naoko Shiba, Xiao Yang, Mitsuto Sato, Shin Kadota, Yota Suzuki, Masahiro Agata, . . . Yuji Shiba. (2023). Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1. Elsevier.
Chicago Style (17th ed.) CitationNaoko Shiba, et al. Efficacy of Exon-skipping Therapy for DMD Cardiomyopathy with Mutations in Actin Binding Domain 1. Elsevier, 2023.
MLA (9th ed.) CitationNaoko Shiba, et al. Efficacy of Exon-skipping Therapy for DMD Cardiomyopathy with Mutations in Actin Binding Domain 1. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.